Breaking Finance News

Numis announced Spire Healthcare Group (LON:SPI), upholding its stock price target at 350.00GBX today

Just yesterday Spire Healthcare Group (LON:SPI) traded -15.78% lower at 261.55GBX. Spire Healthcare Group’s 50-day moving average is 332.64GBX and its 200-day moving average is 333.99GBX. The last stock price is down -21.85% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.04% over the same time period. 1,624,204 shares of SPI traded hands, up from an average trading volume of 852,648

In a report released on Thursday September 14, 2017 Numis hold steady the stock price target of Spire Healthcare Group (LON:SPI) from 350.00GBX to 350.00GBX reporting a possible upside of 0.34%.

Previously on 08/31/2017, Liberum Capital released a statement about Spire Healthcare Group (LON:SPI) reduced the target price from 365.00GBX to 350.00GBX. At the time, this indicated a possible downside of -0.05%.

Recent Performance Chart

Spire Healthcare Group (LON:SPI)

Spire Healthcare Group has 52 week low of 230.40GBX and a 52 week high of 411.00GBX with a PE ratio of 19.62 and has a market capitalization of 0 GBX.

In addition to Numis reporting its stock price target, a total of 7 brokerages have issued a research note on the company. The average stock price target is 57.14GBX with 1 brokerage rating the stock a strong buy, 4 brokerages rating the stock a buy, 4 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Spire Healthcare Group (LON:SPI)

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.